Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2. [electronic resource]
Producer: 20190311Description: 1007 p. digitalISSN:- 1471-2407
- Adult
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Dose-Response Relationship, Drug
- Female
- Fever -- chemically induced
- Humans
- Immunotherapy -- adverse effects
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Staging -- methods
- Renal Insufficiency -- chemically induced
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.